Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...

Platelet spreading and clot contraction are controlled by different pathways. This discovery leads to safer treatments for ...

Coagulation of blood involves proteins called clotting factors. A total of 13 clotting factors - designated by Roman numerals I to XIII - are found in the blood. Injury to blood vessel triggers ...

The FDA approved fitusiran (Qfitlia, Sanofi) for routine prophylaxis for prevention or reduction in bleeding episodes in ...

The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...

Clotting factors and platelets are components of the blood required for proper and effective blood clots formation. The ...

This typically arises from insufficient protein or clotting factors in the bloodstream. Although it is hereditary, ...

factor VII from 16.1 to 63.9 units, and factor X from 13.8 to 65.5 units per milliliter. (One unit of a clotting factor is the amount in 1 ml of normal plasma.) Progressive modifications in the ...

The liver is the site of synthesis of all clotting factors except factor VIII; therefore in liver disease there will be prolonged values due to a lack of factor production. Transfusing the patient ...